| Nuclein, LLC | US | unknown | $19.1M |
| Nuclera | GB | series-b+ | $200.0M |
| Nucleus Genomics | US | series-a | $32.0M |
| Nucleus Genomics | US | series-a | $18.0M |
| Nucleus Genomics | US | series-a | $32.0M |
| Numab Therapeutics | CH | series-b+ | $220.0M |
| NURELM, INC. | US | unknown | $1.9M |
| NUSHORES BIOSCIENCES LLC | US | unknown | $3.0M |
| Nutropy | FR | seed | $7.6M |
| NVision | DE | series-b+ | $55.0M |
| NYTRICX INC | US | unknown | $2.3M |
| OCEANIT LABORATORIES INC | US | unknown | $4.1M |
| Octarine Bio | DK | series-a | $13.8M |
| Oculis | CH | series-b+ | $114.7M |
| OCULO THERAPY LLC | US | unknown | $2.1M |
| Olio Labs | US | seed | $1.0M |
| Onc.AI, Inc. | US | unknown | $2.0M |
| Onepot AI | US | seed | $13.0M |
| Onyx Bio, Inc. | US | unknown | $8.0M |
| Opsiclear LLC | US | unknown | $1.9M |
| Orbis Medicines | DK | seed | $28.1M |
| ORBIT GENOMICS, INC. | US | unknown | $2.0M |
| Orbital Paradigm | ES | pre-seed | $1.6M |
| OREGON RESEARCH BEHAVIORAL INTERVENTION STRATEGIES, INC. | US | unknown | $1.9M |
| Ouro Medicines | US | series-a | $120.0M |
| Overseed | FR | series-a | $7.2M |
| Overseed | FR | series-a | $7.2M |
| Oxus | US | seed | $1.0M |
| Pantera Bio | BE | series-a | $100.4M |
| PASCALL Systems, Incorporated | US | unknown | $2.5M |
| Pathios Therapeutics | GB | series-b+ | $25.3M |
| Pathos | US | series-b+ | $500.0M |
| Patina | US | seed | $2.0M |
| Paulex Bio Inc. | US | unknown | $18.5M |
| Pearl Diagnostics, Inc. | US | unknown | $11.2M |
| Pelage Pharmaceuticals | US | series-b+ | $120.0M |
| Peptilogics | US | series-b+ | $78.0M |
| PERFUSION MEDICAL LLC | US | unknown | $3.0M |
| Periodic Labs | US | seed | $300.0M |
| PEROSPHERE TECHNOLOGIES INC. | US | unknown | $2.0M |
| Phagos | FR | series-a | $27.0M |
| PhaseV | US | series-a | $65.0M |
| Photothermal Spectroscopy Corp | US | unknown | $1.9M |
| PHOTOZIG INC | US | unknown | $2.0M |
| PICCOLO MEDICAL, INC. | US | unknown | $3.0M |
| PINK CLOUD, INC. | US | unknown | $1.9M |
| PLAKOUS THERAPEUTICS, INC. | US | unknown | $2.1M |
| Planetary | CH | series-a | $31.3M |
| Planetary | CH | series-a | $37.4M |
| Point Designs, Inc. | US | unknown | $2.0M |
| PolyModels Hub | FR | seed | $8.5M |
| POP Biotechnologies Inc. | US | unknown | $1.9M |
| Portal Biotech | GB | series-a | $43.2M |
| POTENTIOMETRIC PROBES LLC | US | unknown | $1.9M |
| PRIMETIME LIFE SCIENCES, LLC | US | unknown | $2.5M |
| PRO THERAPEUTICS LLC | US | unknown | $1.8M |
| Profluent | US | series-a | $44.0M |
| Protego Biopharma | US | series-b+ | $130.0M |
| Protego Biopharma | US | series-b+ | $182.0M |
| PROTEINACEOUS, INC. | US | unknown | $1.9M |
| Proteine Resources | PL | series-a | $13.0M |
| PROTHERA BIOLOGICS, INC. | US | unknown | $2.8M |
| Proxima | US | series-b+ | $80.0M |
| Proxima | US | seed | $86.3M |
| PYRAMID TECHNICAL CONSULTANTS, INC | US | unknown | $2.0M |
| QATCH TECHNOLOGIES LLC | US | unknown | $1.9M |
| Qlaris Bio, Inc. | US | unknown | $5.6M |
| Qorium | NL | series-a | $23.8M |
| QUANTITATIVE BIOSCIENCES, INC. | US | unknown | $1.6M |
| QUANTUM APPLIED SCIENCE & RESEARCH INC | US | unknown | $2.9M |
| QUANTUM SIMULATION TECHNOLOGIES INC | US | unknown | $2.0M |
| Quarry DAC, Inc | US | unknown | $2.1M |
| QuberTech | GB | seed | $4.3M |
| RAMONA OPTICS INC | US | unknown | $2.0M |
| RAPIDFORT INC | US | unknown | $1.9M |
| RATTAN LIFE SCIENCE INC | US | unknown | $1.2M |
| Ray Therapeutics | US | series-b+ | $200.0M |
| Raycaster | US | seed | $1.0M |
| ReactWise | US | seed | $1.0M |
| Recombinant Technologies LLC | US | unknown | $2.2M |
| REJUVENATION TECHNOLOGIES INC | US | unknown | $2.5M |
| Reliant AI | DE | seed | $11.0M |
| RELIANT GLYCOSCIENCES LLC | US | unknown | $1.9M |
| Renasant Bio, Inc. | US | unknown | $30.0M |
| Reprise Biomedical, Inc. | US | unknown | $1.4M |
| Resalis | IT | series-a | $10.8M |
| RESTOREAR DEVICES LLC | US | unknown | $1.9M |
| Resurrect Bio | GB | series-a | $11.1M |
| Retro Biosciences | US | series-a | $1.2B |
| Reveal Pharmaceuticals, Inc. | US | unknown | $4.0M |
| Rhizome AI | US | seed | $1.0M |
| Sable Bio | GB | seed | $3.4M |
| SAGE SCIENCE, INC. | US | unknown | $2.0M |
| sallea | CH | seed | $2.6M |
| Sanegene Bio | US | series-b+ | $118.0M |
| Science Corp | US | series-b+ | $490.0M |
| Science Corp | US | series-b+ | $230.0M |
| Scoop | US | seed | $1.0M |
| Scripta Therapeutics | GB | seed | $11.1M |
| Scripta Therapeutics | GB | seed | $11.1M |